Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Liquid medicine for treating infective molluscum contagiosum

An infectious and potion technology, applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve the problem of unsatisfactory curative effect, and achieve the effect of safety, no toxic side effects, definite curative effect and good effect.

Inactive Publication Date: 2016-06-01
DENGFENG TONGDA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Modern medicine generally uses antiviral drugs in the treatment of this disease, but the curative effect is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013] 1. Formula and weight ratio: Drynaria 15 parts, Banlangen 30 parts, Brucea javanica 12 parts, safflower 15 parts, Shanzi mushroom 25 parts, honeysuckle 30 parts.

[0014] 2. Production method: the above-mentioned raw materials are weighed and prepared according to the proportion, processed with pharmaceutical equipment to pass the standard, purified, concentrated and mixed evenly to make a fine powder and a blending agent in proportion to make a liquid medicine for external use to rub the warts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a liquid medicine for treating infective molluscum contagiosum, and belongs to the technical field of traditional Chinese medicinal preparations. The liquid medicine is mainly formed by rhizoma drynariae, isatis root, Brucea javanica, safflower, Pseudobulbus Cremastrae seu Pleiones and honeysuckle flower, and above raw medicines are processed through a pharmaceutical device to prepare the liquid medicine for external use. The liquid medicine has qi and blood regulating, heat clearing and detoxifying functions, and has the advantages of good infective molluscum contagiosum treatment effect, scrubbing convenience, safety and effectiveness.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine preparations. Background technique [0002] Molluscum contagiosum is a hemispherical protrusion, grayish white, milky white or normal in color, smooth as wax, with a sunken center, and cheese-like substances can be extruded. Modern medicine generally uses antiviral drugs for the treatment of this disease, but the curative effect is not ideal. Contents of the invention [0003] The purpose of the invention is to overcome the deficiencies of the prior art and provide a liquid medicine for treating molluscum contagiosum. It has the functions of regulating qi and activating blood circulation, clearing heat and detoxifying, and is effective in treating molluscum contagiosum. The purpose of rubbing convenience, safety and effectiveness can be achieved. [0004] The technical scheme adopted by the present invention to solve the technical problem is: composed of drynaria rhizoma ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P31/20A61P17/12
Inventor 陈冠卿王芳陈洪波
Owner DENGFENG TONGDA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products